Efficacy and tolerability of once-weekly selinexor, bortezomib, and dexamethasone in comparison with standard twice-weekly bortezomib and dexamethasone in previously treated multiple myeloma with renal impairment: Subgroup analysis from the BOSTON study

1. Delimpasi, S.
2. Mateos, M.V.
3. Auner, H.W.
4. Gavriatopoulou, M.
5. Dimopoulos, M.A.
6. Quach, H.
7. Pylypenko, H.
8. Hájek, R.
9. Leleu, X.
10. Dolai, T.K.
11. Sinha, D.K.
12. Venner, C.P.
13. Benjamin, R.
14. Garg, M.K.
15. Doronin, V.
16. Levy, Y.
17. Moreau, P.
18. Chai, Y.
19. Arazy, M.
20. Shah, J.
21. Shacham, S.
22. Kauffman, M.G.
23. Richardson, P.G.
24. Grosicki, S.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1002/AJH.26434 GOOGLE SCHOLAR lock_openOpen access editor

Data source: Scopus